Cancer Immunotherapy: a Step Change in Cancer Treatment

This course will teach you about the power of your immune system and how new immunotherapies are transforming cancer treatment.

Why join the course?

Over 12 million people die of cancer worldwide each year. Although treatments are improving, there is still a long way to go, and some cancers are still a long way to go, and some cancers are still very difficult to treat. Consequently, there is a desperate need for new treatment approaches.

Who is the Course for?

This course will be relevant if you are interested in cancer, or enjoy learning about the immune system and medicine. Secondary or high school-level Knowledge of science is sufficient to complete this course. There will also be optional, additional materials for those already educated to undergraduate level, and those who would like to challenge themselves and explore beyond the core material.

Who will you learn with?

Ben Willcox

Ben is Professor of molecular Immunology at the University of Birmingham. He leads a team researching immune receptors and developing new cancer immunotherapies. He also teaches extensively.

Heather Long

Dr Heather Long is an Immunologist and lecturer with an interest in the immune response to cancer-associated viruses. Her group is focused on identifying immune cells with therapeutic potential.